Having gawped in wonder at Gaudi's unfinished cathedral of countless sky scraping spires straddling 144 years of construction and strolled down Las Ramblas for a coffee or something slightly stronger, ...
Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results